WO1999067382A3 - Angiopoietin-like growth factor sequences - Google Patents
Angiopoietin-like growth factor sequences Download PDFInfo
- Publication number
- WO1999067382A3 WO1999067382A3 PCT/IL1999/000343 IL9900343W WO9967382A3 WO 1999067382 A3 WO1999067382 A3 WO 1999067382A3 IL 9900343 W IL9900343 W IL 9900343W WO 9967382 A3 WO9967382 A3 WO 9967382A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid sequences
- angiopoietin
- growth factor
- amino acid
- factor sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU46436/99A AU4643699A (en) | 1998-06-24 | 1999-06-23 | Angiopoietin-like growth factor sequences |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9048198P | 1998-06-24 | 1998-06-24 | |
US60/090,481 | 1998-06-24 | ||
US10586998P | 1998-10-27 | 1998-10-27 | |
US60/105,869 | 1998-10-27 | ||
IL129027 | 1999-03-17 | ||
IL12902799A IL129027A0 (en) | 1999-03-17 | 1999-03-17 | Novel nucleic acid and amino acid sequence |
IL12937899A IL129378A0 (en) | 1999-04-09 | 1999-04-09 | Novel nucleic acid and amino acid sequences |
IL129378 | 1999-04-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999067382A2 WO1999067382A2 (en) | 1999-12-29 |
WO1999067382A3 true WO1999067382A3 (en) | 2000-04-27 |
Family
ID=27452516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL1999/000343 WO1999067382A2 (en) | 1998-06-24 | 1999-06-23 | Angiopoietin-like growth factor sequences |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4643699A (en) |
WO (1) | WO1999067382A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030831A (en) * | 1997-09-19 | 2000-02-29 | Genetech, Inc. | Tie ligand homologues |
DK1623989T3 (en) * | 1999-03-08 | 2007-10-15 | Genentech Inc | Compositions and Methods for Diagnosing Tumors |
CA2361849A1 (en) * | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
AU5979300A (en) * | 1999-07-02 | 2001-01-22 | Bayer Aktiengesellschaft | Angiopoietin-6 and uses thereof |
JP2003505350A (en) * | 1999-07-20 | 2003-02-12 | ジェネンテック・インコーポレーテッド | Compositions and methods for the treatment of immune related diseases |
EP1239050A4 (en) * | 1999-12-09 | 2004-07-21 | Sankyo Co | Method of testing remedy or preventive for hyperlipemia |
WO2001077151A2 (en) * | 2000-04-07 | 2001-10-18 | Millennium Pharmaceuticals, Inc. | Fdrg proteins and nucleic acid molecules and uses therefor |
EP1403367A4 (en) * | 2001-06-08 | 2005-08-17 | Sankyo Co | Method of testing drug for treating or preventing diseases such as hyperlipemia |
US20050123925A1 (en) | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
JP5105696B2 (en) * | 2001-11-16 | 2012-12-26 | ジェネンテック, インコーポレイテッド | Angiopoietin-like protein 3 Angptl3-containing composition and method of use thereof |
JP2006501849A (en) * | 2002-10-04 | 2006-01-19 | ヴァン アンデル リサーチ インスティチュート | Molecular subclassification of renal tumors and discovery of novel diagnostic markers |
US8604185B2 (en) | 2004-07-20 | 2013-12-10 | Genentech, Inc. | Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
RU2380411C2 (en) | 2004-07-20 | 2010-01-27 | Дженентек, Инк. | Method for inhibition of hepatocyte proliferation, method for inhibition of hepatocyte cell adhesion and method for inhibition of biological activity angptl4 in hepatocytes or hepatocyte precursors |
EP1771474B1 (en) | 2004-07-20 | 2010-01-27 | Genentech, Inc. | Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
US7655762B2 (en) | 2005-01-07 | 2010-02-02 | Lexicon Pharmaceuticals, Inc. | Monoclonal antibodies against ANGPTL4 |
HUE033960T2 (en) | 2006-12-08 | 2018-01-29 | Lexicon Pharmaceuticals Inc | Monoclonal antibodies against angptl3 |
CA2767826C (en) | 2009-07-14 | 2015-11-24 | The Scripps Research Institute | Mesenchymal stem cell differentiation using aniopoietin-like-3 |
US9301971B2 (en) | 2013-03-08 | 2016-04-05 | Novartis Ag | Peptides and compositions for treatment of joint damage |
JO3564B1 (en) | 2013-03-08 | 2020-07-05 | Novartis Ag | Peptides and compositions for treatment of joint damage |
TW202027794A (en) | 2018-10-03 | 2020-08-01 | 瑞士商諾華公司 | Sustained delivery of angiopoetin-like 3 polypeptides |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993000353A1 (en) * | 1991-06-20 | 1993-01-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Sequences characteristic of human gene transcription product |
WO1996031598A1 (en) * | 1995-04-06 | 1996-10-10 | Regeneron Pharmaceuticals, Inc. | Tie-2 ligands, methods of making and uses thereof |
WO1997048804A2 (en) * | 1996-06-19 | 1997-12-24 | Regeneron Pharmaceuticals, Inc. | Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
WO1998005779A1 (en) * | 1996-08-02 | 1998-02-12 | Regeneron Pharmaceuticals, Inc. | Modified tie-2-receptor ligands |
WO1999015653A2 (en) * | 1997-09-19 | 1999-04-01 | Genentech, Inc. | Tie ligand homologues |
WO1999015654A2 (en) * | 1997-09-19 | 1999-04-01 | Genentech, Inc. | Tie receptor tyrosine kinase ligand homologues |
WO1999032515A2 (en) * | 1997-12-19 | 1999-07-01 | Zymogenetics, Inc. | Angiopoietin homolog, dna encoding it, and method of making it |
-
1999
- 1999-06-23 WO PCT/IL1999/000343 patent/WO1999067382A2/en active Application Filing
- 1999-06-23 AU AU46436/99A patent/AU4643699A/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993000353A1 (en) * | 1991-06-20 | 1993-01-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Sequences characteristic of human gene transcription product |
WO1996031598A1 (en) * | 1995-04-06 | 1996-10-10 | Regeneron Pharmaceuticals, Inc. | Tie-2 ligands, methods of making and uses thereof |
WO1997048804A2 (en) * | 1996-06-19 | 1997-12-24 | Regeneron Pharmaceuticals, Inc. | Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
WO1998005779A1 (en) * | 1996-08-02 | 1998-02-12 | Regeneron Pharmaceuticals, Inc. | Modified tie-2-receptor ligands |
WO1999015653A2 (en) * | 1997-09-19 | 1999-04-01 | Genentech, Inc. | Tie ligand homologues |
WO1999015654A2 (en) * | 1997-09-19 | 1999-04-01 | Genentech, Inc. | Tie receptor tyrosine kinase ligand homologues |
WO1999032515A2 (en) * | 1997-12-19 | 1999-07-01 | Zymogenetics, Inc. | Angiopoietin homolog, dna encoding it, and method of making it |
Non-Patent Citations (4)
Title |
---|
DATABASE EMEST 30 E.M.B.L. Databases; 5 August 1993 (1993-08-05), ADAMS M ET AL: "Homo sapiens cDNA clone HIBBA76 5' end similar to Fibrinogen, beta chain", XP002118808 * |
DATABASE EMEST29 E.M.B.L. Databases; 28 November 1996 (1996-11-28), MARRA M ET AL: "Mus musculus cDNA clone 479570 5' similar to PIR: JN0596 JN0596 fibrinogen-related protein HFREP-1 precursor", XP002118809 * |
DATABASE EMEST4 E.M.B.L. Databases; 24 April 1998 (1998-04-24), MARRA M ET AL: "Mus musculus cDNA clone 1298657 5' similar to TR:Q28763 FIBRINOGEN ALPHA-E SUBUNIT", XP002129381 * |
HANAHAN D: "Signaling Vascular Morphogenesis and Maintenance", SCIENCE, vol. 277, 4 July 1997 (1997-07-04), pages 48 - 50, XP002118807 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999067382A2 (en) | 1999-12-29 |
AU4643699A (en) | 2000-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999067382A3 (en) | Angiopoietin-like growth factor sequences | |
AU2001241418A1 (en) | Nucleic acids, proteins, and antibodies | |
WO2001079463A3 (en) | Nucleic acids encoding polypeptides having haloperoxidase activity | |
WO2003052057A3 (en) | Egvi endoglucanase and nucleic acids encoding the same | |
WO2001075087A3 (en) | Subtilisin variants | |
WO2000012726A3 (en) | Rationally designed heparinases derived from heparinase i and ii | |
WO2001029222A3 (en) | Polypeptides having phospholipase b activity and nucleic acids encoding same | |
WO2004069184A3 (en) | Methods for treating, preventing and detecting helicobacter infection | |
AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
WO2002062999A8 (en) | Proteins and nucleic acids encoding same | |
CA2361987A1 (en) | Goodpasture antigen binding protein | |
AU5906699A (en) | (neisseria spp.) polypeptide, nucleic acid sequence and uses thereof | |
AU2462399A (en) | Cubilin protein, dna sequences encoding cubilin and uses thereof | |
WO2003062453A3 (en) | Polycystic kidney disease nucleic acids and proteins | |
WO2001036632A3 (en) | Variants of alternative splicing | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
WO1999022005A3 (en) | Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor | |
WO1997032022A3 (en) | Canine ob protein compositions and methods | |
WO2002062964A3 (en) | Ap1 amine oxidase variants | |
WO2001000799A8 (en) | Novel protein and dna thereof | |
AU2002250254A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2788600A (en) | Ve protein and nucleic acid sequences, compositions, and methods for plant pathogen resistance | |
EP1016717A4 (en) | Novel protein remarkably expressed in hepatic cancer, gene encoding the same, antibody thereto, and method for detecting the expression thereof | |
AU6386399A (en) | Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses | |
AU7275900A (en) | Method for determining nucleic and/or amino acid sequences |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |